4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000067
Chief Financial Officer sold 1,780 shares at $33.54 ($59,701)
- Chief Financial Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jones Cecilia · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | 31,829 | D | ||
| 2025-06-24 | Sale : show line 2 in the form 10b5-1 | −1,780 | $33.54 | $59,701 | 30,049 | D |
| Open-market sales · 1,780 sh · avg $33.54 · $59,701 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-24 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −6,000 | 6,000 | D |
Loading xslF345X05/wk-form4_1750973073.xml…